Free Trial

Best Penny Stocks Under $1.00 Right Now

The stock market has had an incredible bull-run since the Great Recession of 2008 and 2009. While stocks are no longer hitting new all-time highs, the price-to-earnings ratios of most S&P 500 companies still look somewhat expensive historically speaking. Many investors are having trouble finding low-priced stocks that have great business fundamentals and actually generate cash flow.

Stocks have gotten expensive both in-terms of share price and their valuation relative to earnings. In more normal markets, a typical S&P 500 company has traded at about fifteen times their earnings. Most stocks are currently trading closer to 20 times their annual earnings. While the stock market is more expensive as a whole than it has been historically, there are still a handful of undervalued stocks that are trading at less than $1.00 per share.

Value investing opportunities do exist if you're looking in the right places. Putting together a list of the best stocks under $1.00 requires investors to look at smaller and riskier companies and in sectors that are either undiscovered or unloved by the market as a whole. Some of these cheap stocks may not look especially attractive today, but long-term investors will profit if they are willing to exercise patience and hold on to shares of these companies through multiple economic cycles.

Some of these companies are solid investing ideas because they are too little and considered too risky to attract the interest of most managed mutual funds and Wall Street money managers. Others operate in unloved and untested areas of the market. You may find even find crypto stocks, marijuana stocks, and biotechnology stocks on this list. Others have been beat up by Mr. Market after a long period of slowing profits, but are now actively trying to turn around their business and bounce back. These low-priced stocks operate in a lot of different industries, but these picks all carry two common characteristics. They all have a super-low share price of $1.00 (1 dollar) or less and consistently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

GeoVax Labs stock logo

1. GeoVax Labs NASDAQ:GOVX

$0.65 +0.01 (+0.91%)
As of 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$10.32 million
Consensus Rating
Buy
Consensus Price Target
$11.10 (+1,597.5% Upside)
Volume
4.47 million shares
Average Volume
2.85 million shares
Today's Range
$0.65
$0.77
Reviva Pharmaceuticals stock logo

2. Reviva Pharmaceuticals NASDAQ:RVPH

$0.39 +0.01 (+3.53%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 0.00 (-0.23%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$18.08 million
Consensus Rating
Buy
Consensus Price Target
$9.00 (+2,208.3% Upside)
Volume
3.19 million shares
Average Volume
1.38 million shares
Today's Range
$0.38
$0.40
Immunic stock logo

3. Immunic NASDAQ:IMUX

$0.81 -0.02 (-2.82%)
Closing price 04:00 PM Eastern
Extended Trading
$0.81 +0.01 (+0.77%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$79.45 million
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,339.6% Upside)
Volume
663,130 shares
Average Volume
979,124 shares
Today's Range
$0.78
$0.83
Ovid Therapeutics stock logo

4. Ovid Therapeutics NASDAQ:OVID

$0.44 +0.01 (+1.72%)
Closing price 04:00 PM Eastern
Extended Trading
$0.44 +0.00 (+0.37%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$30.58 million
Consensus Rating
Buy
Consensus Price Target
$3.13 (+614.4% Upside)
Volume
1.54 million shares
Average Volume
447,812 shares
Today's Range
$0.40
$0.46
FibroBiologics stock logo

5. FibroBiologics NASDAQ:FBLG

$0.66 +0.05 (+9.04%)
Closing price 04:00 PM Eastern
Extended Trading
$0.67 +0.01 (+1.06%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$23.16 million
Consensus Rating
Buy
Consensus Price Target
$13.00 (+1,869.7% Upside)
Volume
685,126 shares
Average Volume
305,370 shares
Today's Range
$0.61
$0.67
Stardust Power stock logo

6. Stardust Power NASDAQ:SDST

$0.24 +0.01 (+4.17%)
Closing price 04:00 PM Eastern
Extended Trading
$0.23 -0.01 (-2.55%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$13.57 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+2,075.5% Upside)
Volume
3.78 million shares
Average Volume
762,639 shares
Today's Range
$0.22
$0.26
Context Therapeutics stock logo

7. Context Therapeutics NASDAQ:CNTX

$0.63 -0.01 (-1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$0.66 +0.02 (+3.64%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$57.68 million
Consensus Rating
Buy
Consensus Price Target
$5.50 (+770.3% Upside)
Volume
112,075 shares
Average Volume
273,072 shares
Today's Range
$0.63
$0.67
Century Therapeutics stock logo

8. Century Therapeutics NASDAQ:IPSC

$0.63 +0.06 (+11.24%)
Closing price 04:00 PM Eastern
Extended Trading
$0.61 -0.01 (-2.35%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Century Therapeutics, Inc, a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. More about Century Therapeutics

Market Capitalization
$48.46 million
Consensus Rating
Buy
Consensus Price Target
$4.20 (+571.2% Upside)
Volume
2.27 million shares
Average Volume
565,173 shares
Today's Range
$0.56
$0.64
Cognition Therapeutics stock logo

9. Cognition Therapeutics NASDAQ:CGTX

$0.53 -0.06 (-9.55%)
Closing price 04:00 PM Eastern
Extended Trading
$0.54 +0.00 (+0.88%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cognition Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. More about Cognition Therapeutics

Market Capitalization
$36.48 million
Consensus Rating
Buy
Consensus Price Target
$2.83 (+432.3% Upside)
Volume
4.85 million shares
Average Volume
3.05 million shares
Today's Range
$0.52
$0.64
Cresco Labs stock logo

10. Cresco Labs OTCMKTS:CRLBF

$0.59 +0.05 (+9.85%)
As of 03:59 PM Eastern

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. More about Cresco Labs

Market Capitalization
$265.15 million
Consensus Rating
Buy
Volume
551,398 shares
Average Volume
432,514 shares
Today's Range
$0.52
$0.60
50-Day Range
$0.43
$0.91
InflaRx stock logo

11. InflaRx NASDAQ:IFRX

$0.89 +0.02 (+2.08%)
Closing price 04:00 PM Eastern
Extended Trading
$0.89 0.00 (-0.35%)
As of 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRx

Market Capitalization
$58.80 million
Consensus Rating
Buy
Consensus Price Target
$6.60 (+638.2% Upside)
Volume
215,162 shares
Average Volume
294,997 shares
Today's Range
$0.86
$0.90
Tenaya Therapeutics stock logo

12. Tenaya Therapeutics NASDAQ:TNYA

$0.67 +0.04 (+6.05%)
Closing price 04:00 PM Eastern
Extended Trading
$0.66 -0.01 (-1.50%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization
$102.94 million
Consensus Rating
Buy
Consensus Price Target
$6.25 (+831.3% Upside)
Volume
2.01 million shares
Average Volume
2.72 million shares
Today's Range
$0.64
$0.68
Mersana Therapeutics stock logo

13. Mersana Therapeutics NASDAQ:MRSN

$0.34 +0.01 (+3.12%)
Closing price 04:00 PM Eastern
Extended Trading
$0.34 +0.00 (+1.42%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mersana Therapeutics, Inc, a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. More about Mersana Therapeutics

Market Capitalization
$40.75 million
Consensus Rating
Buy
Consensus Price Target
$5.20 (+1,442.1% Upside)
Volume
3.11 million shares
Average Volume
2.73 million shares
Today's Range
$0.33
$0.35
FiscalNote stock logo

14. FiscalNote NYSE:NOTE

$0.72 -0.01 (-1.80%)
Closing price 03:57 PM Eastern
Extended Trading
$0.72 0.00 (-0.11%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$115.32 million
Consensus Rating
Buy
Consensus Price Target
$2.63 (+267.9% Upside)
Volume
1.75 million shares
Average Volume
1.87 million shares
Today's Range
$0.70
$0.74
i-80 Gold stock logo

15. i-80 Gold NYSE:IAUX

$0.60 0.00 (-0.53%)
Closing price 04:00 PM Eastern
Extended Trading
$0.60 +0.00 (+0.73%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

i-80 Gold Corp. is a mining company, engages in the exploration, development and production of gold and silver mineral deposits principally in the United States. More about i-80 Gold

Market Capitalization
$473.35 million
P/E Ratio
-1.67
Consensus Rating
Moderate Buy
Consensus Price Target
$2.17 (+260.8% Upside)
Volume
2.12 million shares
Average Volume
6.81 million shares
Shattuck Labs stock logo

16. Shattuck Labs NASDAQ:STTK

$0.82 +0.01 (+1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$0.82 -0.01 (-1.09%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Shattuck Labs, Inc, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. More about Shattuck Labs

Market Capitalization
$38.77 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.50 (+810.2% Upside)
Volume
213,566 shares
Average Volume
330,469 shares
Today's Range
$0.79
$0.84
Biodesix stock logo

17. Biodesix NASDAQ:BDSX

$0.32 +0.02 (+7.52%)
Closing price 04:00 PM Eastern
Extended Trading
$0.31 0.00 (-0.66%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biodesix, Inc operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. More about Biodesix

Market Capitalization
$43.09 million
Consensus Rating
Moderate Buy
Consensus Price Target
$1.75 (+453.6% Upside)
Volume
1.22 million shares
Average Volume
2.47 million shares
Today's Range
$0.30
$0.32
Omega Therapeutics stock logo

18. Omega Therapeutics NASDAQ:OMGA

$0.12 -0.03 (-21.83%)
Closing price 02/24/2025
Extended Trading
$0.12 0.00 (0.00%)
As of 02/24/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega Therapeutics

Market Capitalization
$6.92 million
P/E Ratio
-0.09
Consensus Rating
Moderate Buy
Consensus Price Target
$8.50 (+6,700.0% Upside)
Volume
4.81 million shares
Average Volume
3.60 million shares
ALX Oncology stock logo

19. ALX Oncology NASDAQ:ALXO

$0.50 +0.04 (+9.07%)
Closing price 04:00 PM Eastern
Extended Trading
$0.50 +0.00 (+0.74%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. More about ALX Oncology

Market Capitalization
$24.49 million
Consensus Rating
Moderate Buy
Consensus Price Target
$3.30 (+559.6% Upside)
Volume
833,306 shares
Average Volume
928,864 shares
Today's Range
$0.45
$0.51
Sangamo Therapeutics stock logo

20. Sangamo Therapeutics NASDAQ:SGMO

$0.53 +0.02 (+2.93%)
Closing price 04:00 PM Eastern
Extended Trading
$0.52 0.00 (-0.59%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sangamo Therapeutics, Inc, a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. More about Sangamo Therapeutics

Market Capitalization
$119.17 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.50 (+755.4% Upside)
Volume
4.78 million shares
Average Volume
9.05 million shares
Today's Range
$0.51
$0.54
Canaan stock logo

21. Canaan NASDAQ:CAN

$0.70 -0.02 (-2.15%)
Closing price 04:00 PM Eastern
Extended Trading
$0.71 +0.01 (+1.43%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Canaan Inc engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. More about Canaan

Market Capitalization
$266.77 million
Consensus Rating
Moderate Buy
Consensus Price Target
$2.67 (+281.0% Upside)
Volume
36.88 million shares
Average Volume
16.63 million shares
Today's Range
$0.67
$0.75
Adicet Bio stock logo

22. Adicet Bio NASDAQ:ACET

$0.71 +0.03 (+4.42%)
Closing price 04:00 PM Eastern
Extended Trading
$0.72 +0.00 (+0.56%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adicet Bio, Inc, a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. More about Adicet Bio

Market Capitalization
$56.47 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.50 (+951.9% Upside)
Volume
393,082 shares
Average Volume
645,111 shares
Today's Range
$0.68
$0.72
Wag! Group stock logo

23. Wag! Group NASDAQ:PET

$0.18 -0.08 (-29.51%)
Closing price 04:00 PM Eastern
Extended Trading
$0.18 0.00 (-1.34%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! Group

Market Capitalization
$12.91 million
Consensus Rating
Moderate Buy
Consensus Price Target
$4.17 (+2,222.6% Upside)
Volume
5.56 million shares
Average Volume
3.17 million shares
Today's Range
$0.17
$0.21
Applied Therapeutics stock logo

24. Applied Therapeutics NASDAQ:APLT

$0.40 +0.03 (+7.05%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 -0.01 (-2.03%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Applied Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. More about Applied Therapeutics

Market Capitalization
$52.24 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.10 (+1,444.3% Upside)
Volume
2.36 million shares
Average Volume
3.45 million shares
Today's Range
$0.36
$0.40
Carisma Therapeutics stock logo

25. Carisma Therapeutics NASDAQ:CARM

$0.40 0.00 (-1.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 -0.01 (-1.76%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carisma Therapeutics, Inc, a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. More about Carisma Therapeutics

Market Capitalization
$16.80 million
Consensus Rating
Hold
Consensus Price Target
$1.93 (+383.7% Upside)
Volume
528,872 shares
Average Volume
3.72 million shares
Today's Range
$0.38
$0.41